Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
McKinsey
Fuji
AstraZeneca
Chubb
Fish and Richardson
Argus Health
Queensland Health

Generated: October 18, 2018

DrugPatentWatch Database Preview

DIVALPROEX SODIUM - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for divalproex sodium and what is the scope of divalproex sodium patent protection?

Divalproex sodium is the generic ingredient in four branded drugs marketed by Abbvie, Dr Reddys Labs Ltd, Mylan, Zydus Pharms Usa Inc, Abbott, Actavis Labs Fl Inc, Anchen Pharms, Apotex Inc, Aurobindo Pharma Ltd, Lupin, Orchid Hlthcare, Prinston Inc, Sandoz, Sun Pharm Inds, Teva, Unichem Labs Ltd, Upsher-smith Labs, Wockhardt, Amneal Pharms, G And W Labs Inc, Impax Labs, and Reddys, and is included in thirty-four NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for divalproex sodium. Forty-seven suppliers are listed for this compound. There is one tentative approval for this compound.

Synonyms for DIVALPROEX SODIUM
133299-66-8
644VL95AO6
76584-70-8
99-66-1 (Parent)
A838751
AB01568255_01
AB2000231
Abbott 50711
Abbott-50711
AC1Q1V4Q
AC1Q1VPW
AKOS015895200
AN-6581
API0002433
AS-17254
C-19234
C16H31NaO4
CC-27204
CHEBI:4667
CHEMBL2105613
D00304
D03LGY
Delepsine
Depacon (TN)
Depakote
Depakote (TN)
Depakote CP
Depakote ER
Depakote ER (TN)
Depakote Sprinkle
Depakote;Epival
Divalproate
divalproex
Divalproex sodium (USP)
Divalproex sodium [USAN:USP]
Divalproex sodium [USAN]
Divalproex sodium salt
Divalproex sodium, Depakote, Epival
Divalproexsodium
DTXSID70227388
Epilex
Epival
Epival (TN)
Ergenyl Chrono (TN)
FT-0625375
HMS3651C17
I06-0339
LS-101863
MolPort-006-167-562
MSRILKIQRXUYCT-UHFFFAOYSA-M
Natrium hydrogen bis(2-propylvalerat)
OR339103
Pentanoic acid, 2-propyl-, sodium salt (2:1)
pentanoic acid, 2-propyl-, sodium salt(2:1)
potassium valproic acid dipropylacetate
s1703
SCHEMBL40996
Semisodium Valproate
Sodium 2-propylpentanoate 2-propylpentanoic acid
sodium 2-propylpentanoate--2-propylpentanoic acid (1:1)
Sodium 2-propylpentanoate-2-propylpentanoic acid (1:1)
Sodium divalproate
Sodium hydrogen bis(2-propylpentanoate)
Sodium hydrogen bis(2-propylvalerate)
Sodium hydrogen bis(2-propylvalerate), oligomer
Sodium hydrogen divalproate
sodium valproic acid valproate
sodium; 2-propylpentanoate; 2-propylpentanoic acid
Sprinkle
U058
UNII-644VL95AO6
Valance (TN)
Valcote
Valdisoval
Valparin
Valproate semisodique
Valproate semisodique [French]
Valproate semisodium
Valproate semisodium (INN)
Valproate semisodium [INN]
Valproato semisodico
Valproato semisodico [Spanish]
Valproatum seminatricum
Valproatum seminatricum [Latin]
Valproic acid semisodium salt (2:1)
Zalkote. (TN)
Tentative approvals for DIVALPROEX SODIUM
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free TrialEQ 500MG VALPROIC ACIDTABLET, DELAYED RELEASE;ORAL
➤ Try a Free Trial➤ Try a Free TrialEQ 250MG VALPROIC ACIDTABLET, DELAYED RELEASE;ORAL
➤ Try a Free Trial➤ Try a Free TrialEQ 125MG VALPROIC ACIDTABLET, DELAYED RELEASE;ORAL

US Patents and Regulatory Information for DIVALPROEX SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-002 May 31, 2002 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Sandoz DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 078290-001 Jul 29, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-002 May 31, 2002 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Actavis Labs Fl Inc DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 079080-001 Feb 25, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-001 Jul 11, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for DIVALPROEX SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie DEPAKOTE divalproex sodium TABLET, DELAYED RELEASE;ORAL 018723-001 Mar 10, 1983 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-002 May 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-002 May 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie DEPAKOTE divalproex sodium CAPSULE, DELAYED REL PELLETS;ORAL 019680-001 Sep 12, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie DEPAKOTE divalproex sodium TABLET, DELAYED RELEASE;ORAL 018723-002 Mar 10, 1983 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
McKinsey
Fuji
AstraZeneca
Chubb
Fish and Richardson
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.